Singapore markets close in 3 hours 53 minutes
Straits Times Index
3,212.14 -13.21 (-0.41%) Nikkei
26,437.94 -473.26 (-1.76%) Hang Seng
20,179.30 -464.98 (-2.25%) FTSE 100
7,438.09 -80.26 (-1.07%) BTC-USD
29,093.51 -723.39 (-2.43%) CMC Crypto 200
648.19 -22.49 (-3.35%)
Roche Holding AG (RHHBF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 09:30AM EDT
| Previous close | 352.50 |
| Open | 373.50 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 373.50 - 373.50 |
| 52-week range | 341.00 - 473.65 |
| Volume | |
| Avg. volume | 757 |
| Market cap | 282.277B |
| Beta (5Y monthly) | 0.30 |
| PE ratio (TTM) | 22.92 |
| EPS (TTM) | 16.30 |
| Earnings date | N/A |
| Forward dividend & yield | 9.97 (2.67%) |
| Ex-dividend date | 17 Mar 2022 |
| 1y target est | N/A |
- Zacks
Pharma Stock Roundup: PFE's Biohaven Buyout Offer, BAYRY's Q1 Earnings Update
Pfizer (PFE) is set to buy migraine drugmaker, Biohaven Pharmaceuticals for $11.6 billion. Bayer (BAYRY) beats Q1 earnings and sales expectations.
- Zacks
Roche (RHHBY) Phase III NSCLC Study Disappoints, Stock Down
Roche (RHHBY) stock declines as the late-stage study evaluating tiragolumab plus Tecentriq fails to meet its co-primary endpoint of progression-free survival.
- Zacks
Epizyme (EPZM) Q1 Earnings Miss, Revenues Lag Estimates
Epizyme (EPZM) posts a wider-than-expected loss for the first quarter. Revenues also miss estimates. EPZM has multiple pipeline readouts on track for this year.
© 2022 Yahoo. All rights reserved.
